Comment
doi: 10.1016/S2352-3018(17)30154-6.
Epub 2017 Sep 11.
Raltegravir becomes a once daily antiretroviral
Affiliations
- PMID: 28918878
- DOI: 10.1016/S2352-3018(17)30154-6
Item in Clipboard
Comment
Raltegravir becomes a once daily antiretroviral
Lancet HIV.
2017 Nov.
No abstract available
Comment on
-
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.Lancet HIV. 2017 Nov;4(11):e486-e494. doi: 10.1016/S2352-3018(17)30128-5. Epub 2017 Sep 11. Lancet HIV. 2017. PMID: 28918877 Clinical Trial.
Similar articles
-
[Integrase inhibitors - new challenges for the treatment of HIV-1 infections].Med Monatsschr Pharm. 2013 Dec;36(12):448-59; quiz 461-2. Med Monatsschr Pharm. 2013. PMID: 24450269 Review. German.
-
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).Infect Dis (Lond). 2017 Oct;49(10):737-747. doi: 10.1080/23744235.2017.1339325. Epub 2017 Jul 6. Infect Dis (Lond). 2017. PMID: 28683645
-
Five years' real-life experience with raltegravir in a large HIV centre.Int J STD AIDS. 2016 Apr;27(5):387-93. doi: 10.1177/0956462415584485. Epub 2015 Apr 29. Int J STD AIDS. 2016. PMID: 25931236
-
Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.AIDS Res Hum Retroviruses. 2013 Jan;29(1):1-3. doi: 10.1089/aid.2012.0196. Epub 2012 Sep 11. AIDS Res Hum Retroviruses. 2013. PMID: 22889147 No abstract available.
-
Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients.Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1167-76. doi: 10.1517/17425255.2015.1056732. Expert Opin Drug Metab Toxicol. 2015. PMID: 26073580 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
